BR112018005771B1 - Uso de um composto - Google Patents

Uso de um composto Download PDF

Info

Publication number
BR112018005771B1
BR112018005771B1 BR112018005771-1A BR112018005771A BR112018005771B1 BR 112018005771 B1 BR112018005771 B1 BR 112018005771B1 BR 112018005771 A BR112018005771 A BR 112018005771A BR 112018005771 B1 BR112018005771 B1 BR 112018005771B1
Authority
BR
Brazil
Prior art keywords
clause
compound
hair
oxopropanenitrile
diazaspiro
Prior art date
Application number
BR112018005771-1A
Other languages
English (en)
Portuguese (pt)
Other versions
BR112018005771A2 (pt
Inventor
Michael Sierra
Tord Labuda
Atsuo TANIMOTO
Yuichi Shinozaki
Original Assignee
Leo Pharma A/S
Japan Tobacco Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2015190849A external-priority patent/JP2017066061A/ja
Application filed by Leo Pharma A/S, Japan Tobacco Inc. filed Critical Leo Pharma A/S
Publication of BR112018005771A2 publication Critical patent/BR112018005771A2/pt
Publication of BR112018005771B1 publication Critical patent/BR112018005771B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
BR112018005771-1A 2015-09-24 2016-09-22 Uso de um composto BR112018005771B1 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP15186644 2015-09-24
EP15186644.9 2015-09-24
JP2015190849A JP2017066061A (ja) 2015-09-29 2015-09-29 円形脱毛症治療剤
JP2015-190849 2015-09-29
PCT/EP2016/072531 WO2017050891A1 (en) 2015-09-24 2016-09-22 Treatment of alopecia areata

Publications (2)

Publication Number Publication Date
BR112018005771A2 BR112018005771A2 (pt) 2018-10-09
BR112018005771B1 true BR112018005771B1 (pt) 2023-12-05

Family

ID=57047187

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112018005771-1A BR112018005771B1 (pt) 2015-09-24 2016-09-22 Uso de um composto

Country Status (27)

Country Link
US (3) US20180263986A1 (cg-RX-API-DMAC7.html)
EP (1) EP3352734B1 (cg-RX-API-DMAC7.html)
JP (1) JP6776345B2 (cg-RX-API-DMAC7.html)
KR (1) KR102728341B1 (cg-RX-API-DMAC7.html)
CN (1) CN108135834B (cg-RX-API-DMAC7.html)
AU (3) AU2016325388A1 (cg-RX-API-DMAC7.html)
BR (1) BR112018005771B1 (cg-RX-API-DMAC7.html)
CA (1) CA2998972A1 (cg-RX-API-DMAC7.html)
CY (1) CY1122837T1 (cg-RX-API-DMAC7.html)
DK (1) DK3352734T3 (cg-RX-API-DMAC7.html)
ES (1) ES2779762T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20200472T1 (cg-RX-API-DMAC7.html)
HU (1) HUE049052T2 (cg-RX-API-DMAC7.html)
IL (3) IL312861A (cg-RX-API-DMAC7.html)
LT (1) LT3352734T (cg-RX-API-DMAC7.html)
MX (1) MX375024B (cg-RX-API-DMAC7.html)
MY (1) MY196541A (cg-RX-API-DMAC7.html)
PL (1) PL3352734T3 (cg-RX-API-DMAC7.html)
PT (1) PT3352734T (cg-RX-API-DMAC7.html)
RS (1) RS60365B1 (cg-RX-API-DMAC7.html)
RU (1) RU2754997C2 (cg-RX-API-DMAC7.html)
SG (1) SG10202111361TA (cg-RX-API-DMAC7.html)
SI (1) SI3352734T1 (cg-RX-API-DMAC7.html)
TW (1) TWI720022B (cg-RX-API-DMAC7.html)
UA (1) UA124192C2 (cg-RX-API-DMAC7.html)
WO (1) WO2017050891A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201801722B (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN119367282A (zh) * 2019-12-27 2025-01-28 乐敦制药株式会社 水性组合物
WO2023029943A1 (zh) * 2021-09-03 2023-03-09 星药科技(北京)有限公司 一种芳杂环化合物及其制备方法和用途
JP2025514747A (ja) 2022-04-20 2025-05-09 レオ ファーマ アクティーゼルスカブ 前頭部線維性脱毛症の治療

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI466885B (zh) * 2009-07-31 2015-01-01 Japan Tobacco Inc 含氮螺環化合物及其醫藥用途
US8637569B2 (en) * 2009-10-22 2014-01-28 Api Genesis, Llc Methods of increasing solubility of poorly soluble compounds and methods of making and using formulations of such compounds
US20140343034A1 (en) * 2013-04-25 2014-11-20 Japan Tobacco Inc. Skin barrier function improving agent
WO2015060208A1 (ja) * 2013-10-21 2015-04-30 日本たばこ産業株式会社 眼疾患の治療剤又は予防剤

Also Published As

Publication number Publication date
JP2018528238A (ja) 2018-09-27
SG10202111361TA (en) 2021-12-30
UA124192C2 (uk) 2021-08-04
LT3352734T (lt) 2020-04-10
RS60365B1 (sr) 2020-07-31
DK3352734T3 (da) 2020-03-30
ZA201801722B (en) 2025-06-25
AU2016325388A1 (en) 2018-03-29
EP3352734B1 (en) 2020-01-15
NZ740690A (en) 2024-11-29
ES2779762T3 (es) 2020-08-19
RU2754997C2 (ru) 2021-09-08
EP3352734A1 (en) 2018-08-01
IL298520A (en) 2023-01-01
SI3352734T1 (sl) 2020-07-31
HUE049052T2 (hu) 2020-09-28
MY196541A (en) 2023-04-19
CA2998972A1 (en) 2017-03-30
CN108135834A (zh) 2018-06-08
US20180263986A1 (en) 2018-09-20
KR20180054767A (ko) 2018-05-24
IL312861A (en) 2024-07-01
AU2024204716B2 (en) 2026-06-11
AU2022202508A1 (en) 2022-05-12
HRP20200472T1 (hr) 2020-09-18
JP6776345B2 (ja) 2020-10-28
US20240398809A1 (en) 2024-12-05
RU2018114922A (ru) 2019-10-28
MX2018003332A (es) 2018-08-16
PL3352734T3 (pl) 2020-08-24
TWI720022B (zh) 2021-03-01
CN108135834B (zh) 2021-07-27
WO2017050891A1 (en) 2017-03-30
PT3352734T (pt) 2020-03-31
RU2018114922A3 (cg-RX-API-DMAC7.html) 2019-12-11
US20220088020A1 (en) 2022-03-24
BR112018005771A2 (pt) 2018-10-09
AU2024204716A1 (en) 2024-07-25
KR102728341B1 (ko) 2024-11-11
MX375024B (es) 2025-03-06
HK1257770A1 (en) 2019-10-25
TW201717955A (zh) 2017-06-01
IL257918A (en) 2018-05-31
CY1122837T1 (el) 2021-05-05

Similar Documents

Publication Publication Date Title
US20240398809A1 (en) Treatment of alopecia areata
ES2425482T3 (es) Antagonista del receptor de angiotensina II para el tratamiento de enfermedades sistémicas en gatos
EP4110326B1 (en) Combination comprising alpelisib and 6-(2,4-dichlorophenyl)-5-[4-[(3s)-1-(3-fluoropropyl)pyrrolidin-3-yl]oxyphenyl]-8,9-dihydro-7h-benzo[7]annulene-2-carboxylic acid
JP6599447B2 (ja) プラダー・ウィリー症候群を治療する方法
JP2024516795A (ja) エベロリムスおよびアムセネストラントを含む組合せ物
BR112020005998A2 (pt) uso de formulação de fenfluramina na redução em número e em frequências de crises convulsivas em populações de pacientes
BR112021010169A2 (pt) elacestrant em combinação com abemaciclib em mulheres com câncer da mama
US20250099468A1 (en) Treating liver disorders with an ssao inhibitor
ES3061585T3 (en) Prophylaxis and treatment of angioedema
US20250275974A1 (en) Treatment of frontal fibrosing alopecia
TW202214249A (zh) 紫質症之預防或治療劑
HK1257770B (en) Treatment of alopecia areata
Ghimire et al. Comparative efficacy of steroid nasal spray versus antihistamine nasal spray in allergic rhinitis
CN106999449A (zh) 用于治疗多汗症的方法
RU2847580C1 (ru) Терапевтическое средство против рака молочной железы
HK40125990A (en) Treatments for cushing's syndrome that do not significantly affect cardiac rhythms
HK40110657A (en) Cdk4 inhibitor for the treatment of cancer
JP2026509959A (ja) ダズコリラントを用いた筋萎縮性側索硬化症のための治療
WO2026021478A1 (zh) Ar降解剂与parp1抑制剂联合用于治疗前列腺癌的方法
TW202506122A (zh) 用於治療acth依賴性庫欣綜合征的黑素皮質素2型(mc2r)受體拮抗劑
BR112015002384B1 (pt) Combinações farmacêuticas compreendendo um inibidor de b-raf e um inibidor de egfr, e seus usos

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B25G Requested change of headquarter approved

Owner name: LEO PHARMA A/S (DK) ; JAPAN TOBACCO INC. (JP)

B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 22/09/2016, OBSERVADAS AS CONDICOES LEGAIS